Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
Date | Price Target | Rating | Analyst |
---|---|---|---|
10/7/2025 | $380.00 | Hold → Buy | TD Cowen |
9/8/2025 | $330.00 | Neutral → Overweight | Analyst |
5/29/2025 | $270.00 → $300.00 | Buy | Needham |
1/23/2025 | $261.00 → $200.00 | Buy → Sell | Goldman |
12/20/2024 | $280.00 | Overweight | Stephens |
12/4/2024 | $275.00 | Outperform | Mizuho |
11/19/2024 | $235.00 | Sector Perform | Scotiabank |
10/8/2024 | $286.00 | Outperform | Exane BNP Paribas |
10-Q - VEEVA SYSTEMS INC (0001393052) (Filer)
8-K - VEEVA SYSTEMS INC (0001393052) (Filer)
8-K - VEEVA SYSTEMS INC (0001393052) (Filer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
PLEASANTON, Calif. and MIAMI, Oct. 16, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) and OpenEvidence today announced the formation of a long-term partnership to jointly create and market Open Vista. Open Vista will use AI to increase patient access to clinical trials, accelerate drug discovery through better understanding of unmet needs, and improve understanding and adoption of existing approved medicines to provide better patient outcomes. "OpenEvidence has become an accelerator for the dissemination of medical knowledge, with more than 40% of U.S. physicians actively usin
Deep, industry-specific agents planned for availability starting this December PLEASANTON, Calif., Oct. 14, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced Veeva AI Agents are planned for availability starting December 2025 for commercial and across R&D and quality in 2026. Veeva AI adds agentic AI to the Veeva Vault Platform and deep, industry-specific agents for Veeva applications in all major areas, including clinical, regulatory, safety, quality, medical, and commercial. Designed for specific, high-impact use cases, Veeva AI Agents understand the Veeva appli
Report shows completing manual data reconciliation, cleaning, and review takes each data manager more than 12 hours per week, per study BALTIMORE, Sept. 29, 2025 /PRNewswire/ -- SCDM 2025 — Two-thirds of data managers and clinical research associates (CRAs) report that inefficiencies in manual data reconciliation, cleaning, and review will put clinical data quality at future risk. The Veeva Clinical Data Industry Research shows the main drivers adding time and effort in executing clinical trials are too many manual steps or data re-entry (68%), inefficient workflows (58%), and using multiple disconnected systems (59%). The findings highlight a need to automate the most inefficient data manag
TD Cowen upgraded Veeva Systems from Hold to Buy and set a new price target of $380.00
Analyst upgraded Veeva Systems from Neutral to Overweight and set a new price target of $330.00
Needham reiterated coverage of Veeva Systems with a rating of Buy and set a new price target of $300.00 from $270.00 previously
Total Revenues of $789.1M, up 17% Year Over YearSubscription Services Revenues of $659.2M, up 17% Year Over Year PLEASANTON, Calif., Aug. 27, 2025 /PRNewswire/ -- Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its second quarter ended July 31, 2025. "It's exciting to see our vision of connected software, data, and business consulting for life sciences becoming a reality," said CEO Peter Gassner. "I am especially excited about the power of Veeva AI and Veeva Data Cloud to enable t
PLEASANTON, Calif., Aug. 6, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) will announce financial results for its second quarter, which ended July 31, 2025, after market close on August 27, 2025. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com at approximately 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event: Veeva Systems' Fiscal 2026 Second Quarter Results Conference Call Date: Wednesday, August 27, 2025 Time: 2:00 p.m. PT (5:00 p.m. ET) Conference Call Registrati
Total Revenues of $759.0M, up 17% Year Over YearSubscription Services Revenues of $634.8M, up 19% Year Over Year PLEASANTON, Calif., May 28, 2025 /PRNewswire/ -- Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its first quarter ended April 30, 2025. "I consider this our best first quarter ever. We executed with speed, quality, and innovation across all areas on short-term objectives and long-term initiatives aligned to our values and 2030 goals," said CEO Peter Gassner. "Thanks t
PLEASANTON, Calif., Jan. 25, 2022 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced the appointments of Tim Cabral, Priscilla Hung, Tina Hunt, and Marshall Mohr to its board of directors. Veeva also announced Ron Codd will retire from the board at the end of his current term in June 2022. "We are pleased to welcome Tim, Priscilla, Tina, and Marshall, who bring a range of experience in life sciences and enterprise software to the Veeva board," said Veeva CEO Peter Gassner. "I would also like to thank Ron Codd for a decade of partnership and contributions to Veeva." Th
BARCELONA, Spain--(BUSINESS WIRE)--Veeva Systems (NYSE: VEEV) announced that in an overwhelming majority vote, 99% of voting shareholders support the company’s proposal to become a public benefit corporation (PBC), including the vast majority of Veeva’s largest shareholders. With shareholder approval, Veeva will become a public benefit corporation on Feb. 1, 2021, making it the first publicly traded company and largest-ever to convert to a PBC. As a PBC, Veeva will remain a for-profit corporation but will be legally responsible to balance the interests of multiple stakeholders, including customers, employees, partners, and shareholders. It will also broaden its certificate of inc
PLEASANTON, Calif.--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions. The updated release reads: VEEVA BECOMES FIRST PUBLIC COMPANY TO CONVERT TO A PUBLIC BENEFIT CORPORATION Aligns legal charter with company’s long-term view and commitment to all stakeholders, including customers, employees, and shareholders Proposal passes by landslide as Veeva garners widespread support for leading in stakeholder capitalism Veeva Systems (NYSE: VEEV) announced that in an overwhelming majority vote today, 99% of voting shareholders support the company’s proposal to become a public benefit corporation (PBC), including the vast majorit
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)